Fig. 2.
Mean semaglutide plasma concentration over time by renal function group after a single dose of semaglutide 0.5 mg. The study period was from Day 1, 0 h (dosing) to Day 21, 480 h (follow-up visit). ESRD end-stage renal disease
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.